# K201907: ClariVein IC

- Pathway: 510(k) (Special)
- Applicant: Merit Medical Systems, Inc.
- Decided: Aug 6, 2020 after 28 days
- Product code: KRA (Catheter, Continuous Flush)
- Device class: 2
- Regulation: 21 CFR 870.1210
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 6 generations back to K904788 (1990). 11 ancestors in all.
2 later devices descend from it; 2 cite it directly.
0 of 14 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K153502: ClariVein IC, Vascular Insights, LLC (2016) Summary page 4.

## Most influential descendants
- K250794: InVera Infusion Device (2026), 0 descendants of its own
- K231148: ScleroSafe™ 150 mm, ScleroSafe™ 350 mm (2023), 0 descendants of its own

## Indications for use
The ClariVein IC is indicated for the infusion of physician-specified agents in the peripheral vasculature (e.g., superficial veins, saphenous veins).

Source page: https://510kreport.com/device/K201907
Methodology: https://510kreport.com/methodology